Screener
Bio-Techne Corp. TECH Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Diagnostics And Spatial Biology | $90.14M+0.5% | $85.59M-4.1% | $81.18M-3.5% | $79.46M-4.5% | $89.71M-1.1% | |
| Protein Sciences | $231.19M+2.1% | $226.15M-0.7% | $215.08M+1.7% | $202.19M-1.1% | $226.47M+5.8% | |
| Revenue by Product | ||||||
| Consumables | $260.73M+3.1% | $257.34M-0.2% | $235.44M+2.0% | $231.6M+0.3% | $252.94M+2.9% | |
| Instruments | $31.54M+9.1% | $27.66M+5.9% | $29.61M-4.1% | $21.83M-16.7% | $28.9M+6.7% | |
| Royalty | $5.87M+6.5% | $4.97M-1.4% | $8.51M+5.1% | $5.65M+11.8% | $5.51M+9.0% | |
| Service | $23.06M-22.1% | $21.45M-21.3% | $22.32M-18.4% | $27.48M+0.5% | $29.62M+5.1% | |
| Revenue by Geography | ||||||
| APAC Excluding Greater China | $22.11M+17.0% | $21.82M+2.7% | $22.74M+19.6% | $19.15M+5.7% | $18.89M-1.9% | |
| CN | $26.91M0.0% | $26.01M+6.2% | $26.35M+6.5% | $24.79M+1.9% | $26.91M+12.5% | |
| EMEA Excluding UK | $80.29M+14.1% | $73.45M+10.4% | $75.35M+7.0% | $65.13M+10.3% | $70.35M+10.7% | |
| GB | $14.46M-2.2% | $14.89M+15.9% | $13.73M+3.7% | $13.21M-5.3% | $14.79M+25.7% | |
| Rest Of World | $11.32M+17.4% | $7.77M-15.4% | $11.15M+14.6% | $9.05M+0.6% | $9.65M-4.0% | |
| US | $166.1M-5.8% | $167.48M-7.9% | $146.56M-8.3% | $155.24M-5.9% | $176.39M-0.6% |
FAQ
- How does Bio-Techne Corp. break its business down?
- Bio-Techne Corp. (TECH) reports revenue by business across 2 parts — Diagnostics And Spatial Biology and Protein Sciences. Each is extracted from the segment footnotes and tracked over time.
- Where does Bio-Techne Corp.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bio-Techne Corp.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
